Reply to thread

txmx


This is what I read yesterday on the Wall Street Journal:


"[h=5]September 22, 2014 10:14 AM[/b]Repros Therapeutics Says FDA Recommendation Not Directly Applicable to Androxal[h=2]Biopharmaceutical Drug Developer Says Androxal Isn't a Form of Testosterone[/b]By Tess Stynes

[h=2]FDA Recommendation Doesn't Apply to Androxal, Repros Says[/b]Repros Therapeutics said a Food and Drug Administration advisory panel recommendation doesn't directly apply to its lead drug candidate to treat low testosterone caused by secondary hypogonadism."


Back
Top